|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
EP0173494A3
(en)
|
1984-08-27 |
1987-11-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Chimeric receptors by dna splicing and expression
|
|
GB8422238D0
(en)
|
1984-09-03 |
1984-10-10 |
Neuberger M S |
Chimeric proteins
|
|
JPS61134325A
(ja)
|
1984-12-04 |
1986-06-21 |
Teijin Ltd |
ハイブリツド抗体遺伝子の発現方法
|
|
JPS63501765A
(ja)
|
1985-11-01 |
1988-07-21 |
インタ−ナショナル、ジェネティック、エンジニアリング インコ−ポレ−テッド |
抗体遺伝子のモジュ−ル組立体、それにより産生された抗体及び用途
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0436597B1
(en)
|
1988-09-02 |
1997-04-02 |
Protein Engineering Corporation |
Generation and selection of recombinant varied binding proteins
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
GB8905669D0
(en)
|
1989-03-13 |
1989-04-26 |
Celltech Ltd |
Modified antibodies
|
|
WO1991000906A1
(en)
|
1989-07-12 |
1991-01-24 |
Genetics Institute, Inc. |
Chimeric and transgenic animals capable of producing human antibodies
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
EP0585287B1
(en)
|
1990-07-10 |
1999-10-13 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
ATE300615T1
(de)
|
1990-08-29 |
2005-08-15 |
Genpharm Int |
Transgene mäuse fähig zur produktion heterologer antikörper
|
|
ATE352612T1
(de)
|
1990-08-29 |
2007-02-15 |
Pharming Intellectual Pty Bv |
Homologe rekombination in säugetier-zellen
|
|
CA2405246A1
(en)
|
1990-12-03 |
1992-06-11 |
Genentech, Inc. |
Enrichment method for variant proteins with alterred binding properties
|
|
EP0575485A1
(en)
|
1991-03-01 |
1993-12-29 |
Dyax Corp. |
Process for the development of binding mini-proteins
|
|
DK0580737T3
(da)
|
1991-04-10 |
2004-11-01 |
Scripps Research Inst |
Heterodimere receptorbiblioteker ved anvendelse af phagemider
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
AU701578B2
(en)
|
1992-08-21 |
1999-02-04 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
EP1356093A2
(en)
*
|
2000-06-21 |
2003-10-29 |
Hitachi Chemical Co., Ltd. |
Gene markers for lung cancer
|
|
CA2486285C
(en)
|
2004-08-30 |
2017-03-07 |
Viktor S. Goldmakher |
Immunoconjugates targeting syndecan-1 expressing cells and use thereof
|
|
EP2567976B1
(en)
*
|
2005-03-23 |
2017-07-19 |
Genmab A/S |
Antibodies against CD38 for treatment of multiple myeloma
|
|
US20070054332A1
(en)
|
2005-08-10 |
2007-03-08 |
Alan Rapraeger |
Syndecan 1 ectodomain inhibits cancer
|
|
EP1914242A1
(en)
|
2006-10-19 |
2008-04-23 |
Sanofi-Aventis |
Novel anti-CD38 antibodies for the treatment of cancer
|
|
EP2240516B1
(en)
|
2007-12-26 |
2015-07-08 |
Biotest AG |
Methods and agents for improving targeting of cd138 expressing tumor cells
|
|
JP2011507933A
(ja)
|
2007-12-26 |
2011-03-10 |
バイオテスト・アクチエンゲゼルシヤフト |
免疫複合体の細胞傷害性副作用の低減及び有効性の改善方法
|
|
CA2710453C
(en)
|
2007-12-26 |
2019-07-02 |
Biotest Ag |
Agents targeting cd138 and uses thereof
|
|
ES2526433T3
(es)
|
2007-12-26 |
2015-01-12 |
Biotest Ag |
Inmunoconjugados dirigidos a CD138 y usos de los mismos
|
|
NZ613647A
(en)
|
2009-05-06 |
2015-02-27 |
Biotest Ag |
Uses of immunoconjugates targeting cd138
|
|
US9249467B2
(en)
|
2011-09-16 |
2016-02-02 |
Steven Goodison |
Bladder cancer detection composition, kit and associated methods
|
|
US10577543B2
(en)
|
2011-10-27 |
2020-03-03 |
Raymond Roger Wallage |
Efficient oil shale recovery method
|
|
MX358680B
(es)
|
2011-12-08 |
2018-08-31 |
Biotest Ag |
Usos de inmunoconjugados dirigidos a cd138.
|
|
KR101721678B1
(ko)
|
2012-03-08 |
2017-03-31 |
할로자임, 아이엔씨 |
조건부 활성 항-표피 성장 인자 수용체 항체 및 이의 사용 방법
|
|
GB201216002D0
(en)
|
2012-09-07 |
2012-10-24 |
Deutsches Rheuma Forschungszentrum Berlin Drfz |
Compositions adn methods
|
|
US9803021B2
(en)
|
2012-12-07 |
2017-10-31 |
The Regents Of The University Of California |
CD138-targeted interferon demonstrates potent apoptotic and anti-tumor activities
|
|
CN103103197A
(zh)
|
2013-01-30 |
2013-05-15 |
百奇生物科技（苏州）有限公司 |
抗cd138单克隆抗体可变区序列及其制备方法和应用
|
|
RU2611685C2
(ru)
*
|
2015-07-20 |
2017-02-28 |
Илья Владимирович Духовлинов |
Гуманизированное моноклональное антитело, специфичное к синдекану-1
|
|
SG11201900616UA
(en)
|
2016-08-02 |
2019-02-27 |
Visterra Inc |
Engineered polypeptides and uses thereof
|
|
CN110691793A
(zh)
|
2017-04-26 |
2020-01-14 |
田边三菱制药株式会社 |
黏结蛋白聚糖-1（cd138）结合剂及其用
|
|
MX2020003783A
(es)
*
|
2017-10-02 |
2021-01-08 |
Visterra Inc |
Moleculas de anticuerpo de cd138 y sus usos.
|
|
JOP20200268A1
(ar)
|
2018-06-01 |
2020-10-26 |
Eisai R&D Man Co Ltd |
تضفير مترافقات عقار جسم مضاد معدل وطرق استخدامها
|
|
CN114144437B
(zh)
|
2019-06-07 |
2025-02-25 |
阿迪马布有限责任公司 |
工程化的pH依赖性抗CD3抗体及其产生和使用方法
|
|
CA3142021A1
(en)
|
2019-06-17 |
2020-12-24 |
Visterra, Inc. |
Humanized antibody molecules to cd138 and uses thereof
|
|
US12590171B2
(en)
*
|
2019-09-27 |
2026-03-31 |
Nanjing GenScript Biotech Co., Ltd. |
Anti-VHH domain antibodies and use thereof
|
|
WO2023097254A1
(en)
|
2021-11-24 |
2023-06-01 |
Visterra, Inc. |
Engineered antibody molecules to cd138 and uses thereof
|